Immunization

The Pharmacy Times® Immunization resource center provides the latest news in immunization. Here, you’ll find information about upcoming conferences and meetings, updated clinical trial listings, and other resources for those interested in vaccination.

What can we help you find?
[[thumbnail_alt_text]]
Immunization needs for patients aged 19 to 64 years and afflicted with chronic conditions are often overlooked, and necessitate more attention and resources. Pharmacies traditionally do not focus on this patient population; instead often choosing to focus primarily on the population 65 years and over. However, engaging with patients in the 19- to 64-year-old group could go a long way in helping to fill the current immunization void in this population.
[[thumbnail_alt_text]]
The study evaluated the safety and efficacy of a live, attenuated zoster vaccine patients receiving tumor necrosis factor inhibitor therapies for various indications.
[[thumbnail_alt_text]]
Community pharmacies that provide immunization services have proven their success time and again, but they still face roadblocks. Many state laws and regulations still do not allow pharmacies to take full responsibility for vaccinations, and states regulate immunization services at pharmacies in different ways.
[[thumbnail_alt_text]]
Previously, vaccination was not recommended for patients in a certain age range, as there was no demonstrated benefit to HPV vaccination; however, this is about to change.
[[thumbnail_alt_text]]
Louisiana and Nevada show the highest flu activity in the first monthly report from the Walgreens Flu Index for October, which shows increased incidence of the flu compared with last year.
[[thumbnail_alt_text]]
According to a study by PMR, the global flu vaccine market is projected to account for a market value of approximately $8 billion by the end of 2029. Increasing vaccination rates and a focus on preventive rather than reactive methods are expected to drive the growth of the market.
[[thumbnail_alt_text]]
Officials from the FDA have cleared an investigational new drug (IND) application for BW-1010 (BlueWillow Biologics), according to the company. The drug would be the company’s next-generation anthrax vaccine candidate.
[[thumbnail_alt_text]]
According to investigators at the National Institutes of Health, a single dose of highly diluted VSV-Ebola virus (EBOV) vaccine is still protective against the disease.
[[thumbnail_alt_text]]
Pharmacists play an important role in educating patients about the importance of vaccinations and the health consequences of refusing them.
[[thumbnail_alt_text]]
The FDA approved Jynneos (Bavarian Nordic) as the first live, nonreplicating vaccine to prevent smallpox and monkeypox.
 
[[thumbnail_alt_text]]
A recent study suggests that vaccination rates in some Texas schools are low enough to allow for large measles outbreaks, but limiting vaccine exemptions could decrease this risk. Vaccine exemptions, which allow unvaccinated children to attend school, have increased by a factor of 28 since 2003 in Texas.
 
[[thumbnail_alt_text]]
Our pharmacist team at Osterhaus Pharmacy has been providing immunizations to our patients for the past 2 decades. However, in the past 3 years we have become more proactive in our approach to discussing immunizations.